Matthew Norkunas
Finanzdirektor/CFO bei GENERATION BIO CO.
Vermögen: 158 392 $ am 30.04.2024
Profil
Matthew Norkunas is currently the Director at Obsidian Therapeutics, Inc. since 2023 and the Chief Financial Officer at Generation Bio Co. since 2020.
Previously, he worked as a Research Analyst at Marsico Capital Management LLC from 2012 to 2013 and as the Chief Financial Officer at SomaLogic Operating Co., Inc. from 2016 to 2020.
Dr. Norkunas completed his undergraduate degree at St. Mary's College (Maryland) in 1999.
He also holds a doctorate degree from the University of Maryland School of Medicine and an MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENERATION BIO CO.
0,08% | 15.04.2024 | 52 622 ( 0,08% ) | 158 392 $ | 30.04.2024 |
Aktive Positionen von Matthew Norkunas
| Unternehmen | Position | Beginn |
|---|---|---|
| GENERATION BIO CO. | Finanzdirektor/CFO | 22.07.2020 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 23.05.2023 |
Ehemalige bekannte Positionen von Matthew Norkunas
| Unternehmen | Position | Ende |
|---|---|---|
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Finanzdirektor/CFO | 01.06.2020 |
Marsico Capital Management LLC
 Marsico Capital Management LLC Investment ManagersFinance Marsico Capital Management LLC (MCM) is a SEC-registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded by Thomas “Tom” Marsico in 1997. MCM manages assets for mutual funds, corporate retirement plans, endowments, foundations, family offices, separately managed wrap programs, and other clients. The firm also serves as the investment adviser to the Marsico Funds. | Analyst-Equity | - |
Ausbildung von Matthew Norkunas
| St. Mary's College (Maryland) | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
| University of Maryland School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENERATION BIO CO. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Marsico Capital Management LLC
Marsico Capital Management LLC Investment ManagersFinance Marsico Capital Management LLC (MCM) is a SEC-registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded by Thomas “Tom” Marsico in 1997. MCM manages assets for mutual funds, corporate retirement plans, endowments, foundations, family offices, separately managed wrap programs, and other clients. The firm also serves as the investment adviser to the Marsico Funds. | Finance |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
